Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Process-for-oligonucleotide-synthesis

 Genetically modified cells expressing a TGF.beta. inhibitor, the cells being lung cancer cells
OF THE PREFERRED EMBODIMENT Lung cancers account for 30% of all death due to cancer in the United S...


 Auto-ligating oligonucleotide compounds
OF THE INVENTION The invention relates to a method and compositions for in situ formation of an ...


 Nucleic acids encoding transcription factor APRF (acute phase response factor)
What is claimed: 1. An isolated DNA molecule which encodes a human APRF polypeptide having the ...


 Antisense modulation of stat3 expression
OF THE INVENTION STAT3 plays an important role in cytokine signal transduction. Overexpression and/...


 Cold-active beta-galactosidase, the process for its preparation and the use thereof
The object of the present invention is to hydrolyse lactose by using a .beta.-galactosidase, which ...


 Method of delivering powder transdermally with needless injector
What we claim is: 1. A method of therapeutic treatment, comprising transdermally delivering ...


 Telomere repeat binding factors and diagnostic and therapeutic use thereof
The present invention provides vertebrate telomeric binding factors (TRFs) that bind to the TTAGGG ...


 Protease-activated receptor PAR4 (ZCHEMR2)
What is claimed is: 1. An isolated polynucleotide molecule that encodes a polypeptide comprising ...


 Systemic drug delivery compositions comprising a polycationi substance
I claim: 1. A method of systemically delivering a pharmaceutically effective amount of a ...


 Nucleic acid-containing composition, its preparation and use
We claim: 1. A composition comprising a deoxyribonucleic acid and a cationic oligopeptide that ...


 Process for oligonucleotide synthesis

Details
Inventors: Scozzari, Anthony;
Assignee: Isis Pharmaceuticals, Inc. (Carlsbad, CA)
Primary Examiner: Tsang; Cecilia
Assistant Examiner: Crane; L. Eric
Attorney, Agent or Firm: Woodcock Washburn Kurtz MacKiewicz & Norris LLP

The present invention describes methods for linking phosphoramidite nucleosides to a solid support-bound nucleoside. This invention presents novel processes for synthesizing oligonucleotides. Acetonitrile having a water content between 30 ppm and about 1250 ppm is used as the solvent for the washing steps in solid phase oligonucleotide synthesis, or is used as a solvent for the capping reagent or oxidizing reagent. The processes of the present invention are amenable to large-scale, economic oligonucleotide synthesis using the phosphoramidite method.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention is directed to methods for linking a phosphoramidite nucleoside to a solid support-bound nucleoside.
These methods comprise attaching a first nucleoside having a protected hydroxyl group to a solid support by means of a covalent linkage.
The first nucleoside may be attached to the solid support either directly or via a linker, using standard methods and procedures known in the art.
See, e.
g.
, Oligonucleotides and Analogues: A Practical Approach, Eckstein, F, Ed.
, IRL Press, New York, 1991, hereby incorporated by reference in its entirety.
One example is a long chain alkylamine linker incorporating a carbamate linkage.
The attached protected nucleoside is then deprotected with a deprotecting reagent and coupled with a second phosphoramidite nucleoside to form a phosphorus nucleoside linkage between the first nucleoside and the second nucleoside.
This coupling occurs at the hydroxyl group, of the first nucleoside, which becomes reactive upon deprotection with the deprotecting reagent.
Following this coupling step, the remaining deprotected but uncoupled first nucleoside is optionally capped with a capping reagent.
The resultant phosphorus nucleoside linkage is next oxidized with an oxidizing agent.
According to the methods of the present invention, during the linking of a phosphoramidite nucleoside to a solid support-bound nucleoside, the solid support is washed with acetonitrile prior to or subsequent to at least one of the coupling, capping or oxidizing steps, wherein the acetonitrile has a water content between 30 ppm and about 1250 ppm, or at least one of the capping or oxidizing reagents is in an acetonitrile solvent having a water content of between 30 ppm and about 1250 ppm.
In a preferred embodiment the solid support is washed with acetonitrile prior to or subsequent to at least one of the coupling, capping or oxidizing steps, wherein the acetonitrile has a water content between 30 ppm and about 1250 ppm, and at least one of the capping or oxidizing reagents is in an acetonitrile solvent having a water content of between 30 ppm and about 1250 ppm



Related patents
  Derivatized oligonucleotides having improved uptake and other properties
OF THE INVENTION Antisense therapeutics can be practiced in a variety of organisms ranging from unicellular prokaryotic and eukaryotic organisms to multicellular ...
  Process for the synthesis of oligomeric compounds
What is claimed is: 1. A compound having the formula: ##STR38## wherein: X.sub.4 is Z or H; Z is CN, a halogen radical, , alkaryl, substituted sulfoxyl, substituted ...
  Processes for the synthesis of oligomeric compounds
OF PREFERRED EMBODIMENTS The present invention provides methods for the preparation of oligomeric compounds having at least one phosphodiester or phosphorothioate ...
  Methods of synthesis and use of radiolabelled platinum chemotherapeutic agents
OF THE INVENTION Usually, in the method of synthesis of the radiolabelled platinum chemotherapeutic agent the step of converting the metal halide into a radiolabelled ...
  Pharmaceutical composition for diabetic neuropathy
What is claimed is: 1. A method for the prophylaxis of diabetic peripheral neuropathy, which comprises administering an effective amount of cytidine 5'-diphosphocholine ...
  Rapid single-cycle assay for human immunodeficiency virus type-1 drug resistance
This invention aids in fulfilling this need in the art by providing an in vitro, single cycle, recombinant virus assay (RVA) for determining inhibition of HIV ...
  Compositions and methods for sensitive detection of HIV infection and monitoring of drug resistance
OF THE INVENTION The present invention relates to new and useful methods including methods for detecting HIV, methods for detecting HIV drug resistance, methods for ...
  Continuous process for ethanol production by bacterial fermentation
The accompanying FIGURE will provide a background for the following discussion in which the method and apparatus for carrying out this invention are described in detail....
  Stable solution of hyaluronate in a balanced salt medium
What is claimed is: 1. A physiological visco-elastic formulation consisting of sodium hyaluronate in an amount in the range of about 0.1% to about 5% by weight in a ...
  Radiolabeled fusion toxins for cancer therapy
The present invention describes the synthesis and purification of a new class of compounds known as radiolabeled fusion toxins (RFT), in which both toxin and ...

0.014

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved